Innate and Adaptive Immunity is not Impacted by Inflammatory Bowel Disease Medications in Pregnant Women and Their Offspring
This study provides the foundation for ongoing investigation to more definitively extricate the impact of maternal IBD activity, drug exposures, and disease phenotype on infant immune system development and function. These novel data suggest that IBD pharmacotherapies may not significantly impact maternal or infant immune regulation.
Authors
- Ralley Prentice (ORCID: https://orcid.org/0000-0002-4331-9295)
- Steven Cho (ORCID: https://orcid.org/0000-0002-4057-2092)
- Claudia A. Nold‐Petry (ORCID: https://orcid.org/0000-0002-7439-3834)
- Marcel F. Nold (ORCID: https://orcid.org/0000-0001-9682-4618)
- Emma Flanagan (ORCID: https://orcid.org/0000-0002-3911-4780)
- Emily K. Wright (ORCID: https://orcid.org/0000-0003-3896-7826)
- Rimma Goldberg (ORCID: https://orcid.org/0000-0002-4984-8585)
- Marie Lee
- Sally Bell (ORCID: https://orcid.org/0000-0002-7002-453X)
- Megan Burns (ORCID: https://orcid.org/0000-0003-2602-1638)
- Indiana Zorkau
Institutions
- The University of Melbourne (AU)
- Hudson Institute of Medical Research (AU)
- St Vincent's Hospital Melbourne (AU)
- Monash Children’s Hospital (AU)
- Monash Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1093/ibd/izaf052
- Primary Topic
- Reproductive System and Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00